Nektar Therapeutics (NASDAQ:NKTR)

Monday’s trading has closed, but NKTR is being traded in the after-hours session. After-Hours quote »
11.31
Delayed Data
As of 4:00pm ET
 +0.22 / +1.98%
Today’s Change
10.10
Today|||52-Week Range
17.53
-27.03%
Year-to-Date

Today’s Trading

Previous close11.09
Today’s open11.14
Day’s range10.63 - 11.31
Volume1,881,519
Average volume (3 months)1,207,181
Market cap$1.5B
Dividend yield--
Data as of 4:00pm ET, 03/30/2015

Growth & Valuation

Earnings growth (last year)+70.00%
Earnings growth (this year)+8.27%
Earnings growth (next 5 years)-8.06%
Revenue growth (last year)+34.77%
P/E ratioNM
Price/Sales9.80
Price/Book40.05

Competitors

 Today’s
change
Today’s
% change
ARIAARIAD Pharmaceutical...+0.17+2.03%
KERXKeryx Biopharmaceuti...+0.34+2.68%
PRAHPRA Health Sciences ...+0.33+1.15%
FGENFibroGen Inc+1.74+5.83%
Data as of 4:00pm ET, 03/30/2015

Financials

Next reporting dateMay 6, 2015
EPS forecast (this quarter)-$0.40
Annual revenue (last year)$200.7M
Annual profit (last year)-$53.9M
Net profit margin-26.86%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Class I Director
Howard W. Robin
Chief Financial Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account